Author:
Fezzi Simone,Castaldi Gianluca,Widmann Maddalena,Ruzzarin Alessandro,Tavella Domenico,Ribichini Flavio
Publisher
Springer Science and Business Media LLC
Reference9 articles.
1. Fezzi S, Castaldi G, Widmann M, Marin F, Ribichini F (2021) The return of renal denervation for the treatment of hypertension: an update on new evidence and clinical indications. G Ital Cardiol 22(3 Suppl 1):17S-24S
2. Marin F, Fezzi S, Gambaro A, Ederle F, Castaldi G, Widmann M et al (2021) Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: first Italian real-world experience. J Nephrol 34(5):1445–1455
3. Schmieder RE, Mahfoud F, Mancia G, Azizi M, Böhm M, Dimitriadis K et al (2021) European Society of Hypertension position paper on renal denervation 2021. J Hypertens 39(9):1733–1741
4. Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM et al (2014) Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med 370(1):13–22
5. Mitchell JA, Subramanian R, White CJ, Soukas PA, Almagor Y, Stewart RE et al (2007) Predicting blood pressure improvement in hypertensive patients after renal artery stent placement: renal fractional flow reserve. Catheter Cardiovasc Interv 69(5):685–689